Lymphoma Management in North Carolina: Updates for 2023 - SPOC

Webinar Information

Webinar Description

Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

Learning Objectives

  • Discuss the use of polatuzumab vedotin in the frontline treatment of diffuse large B cell lymphoma
  • Identify patients with diffuse large B cell lymphoma who are eligible for CAR-T cell therapy
  • Discuss the use of brentuximab vedotin in the frontline treatment of Hodgkin lymphoma

 

Webinar Documents

Handouts

 

Webinar Registration


Take Course

You must have an account and be logged in to register. Please contact us with any questions at [email protected] or (919) 445–1000.

 

You may also be interested in

Caring for the Patient with Hematologic Cancers: Leukemia, Lymphoma, and Multiple Myeloma - CCO SPOC

We will provide an introduction to blood cancers including risk factors, epidemiology, presenting symptoms, general treatment, and caregiver and survivorship issues.
Lymphoma Management Updates for 2021 - SPOC

This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma.
Mantle Cell Lymphoma Management in North Carolina: Updates for 2020 - SPOC

Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina.
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
10/02/2023
Course expires: 
10/31/2027
Research to Practice Logo 

Cancer Treatment in North Carolina: Research to Practice (formerly Medical and Surgical Oncology) webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included.

This series incorporates an understanding of practice dynamics and concerns throughout the state of North Carolina, and the availability of clinical trials and subspecialty expertise to inform care.

These webinars provide FREE continuing education credit.

Photo of Natalie Grover, MD 

Natalie Grover, MD

Assistant Professor of Medicine
Division of Hematology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

This Non-Credit Course does not have accreditation. It only offers general participation certificates.

Available Credit

  • 1.00 Participation
Please login or register to take this course.

You must have an account and be logged in to register for and to access the course.

Requirements for Receiving Free General Participation Certificates

  • Watch the video
  • Complete the assessment with a score of 80% or better
  • Complete the evaluation
  • Download the certificate